Changes in the biochemical and immunological components of serum and colostrum of overweight and obese mothers

BMC Pregnancy and Childbirth

Volumn 15, Issue 1, 2015, Pages

  Fujimori, Mahmi ^a   França, Eduardo L ^b   Fiorin, Vanessa ^c   Morais, Tassiane C ^a,b   Honorio França, Adenilda C ^b   de Abreu, Luiz C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

^c FACULDADE DE MEDICINA DO ABC   (Brazil)

Author keywords

Antibody; Colostrum; Complement protein; Fat; Obesity

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; GLUCOSE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TRIACYLGLYCEROL; FAT; GLUCOSE BLOOD LEVEL; IMMUNOGLOBULIN; PROTEIN;

ADULT; ARTICLE; BIOCHEMICAL COMPOSITION; BLOOD SAMPLING; BODY WEIGHT; CALORIE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COLOSTRUM; CONTROLLED STUDY; FAT CONTENT; FEMALE; HUMAN; MATERNAL OBESITY; PROTEIN BLOOD LEVEL; SERUM; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; GLUCOSE BLOOD LEVEL; IMMUNOLOGY; METABOLISM; OBESITY; PREGNANCY; PREGNANCY COMPLICATION; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHOLESTEROL; COLOSTRUM; COMPLEMENT C3; COMPLEMENT C4; CROSS-SECTIONAL STUDIES; FATS; FEMALE; GLUCOSE; HUMANS; IMMUNOGLOBULINS; OBESITY; OVERWEIGHT; PREGNANCY; PREGNANCY COMPLICATIONS; PROTEINS; TRIGLYCERIDES; YOUNG ADULT;

EID: 84938852336     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/s12884-015-0574-4     Document Type: Article

References (51)

1. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation, World Health Organization Technical Report Series. Geneva, Switzerland: World Health Organization; 2000.
2. França EL, Nicomedes TR, Calderon IMP, Honório-França AC. Time-dependent alterations of soluble and cellular components in human milk. Biol Rhythm Res. 2010;41:333-47.
3. França EL, Bitencourt RV, Fujimori M, Morais TC, Calderon IMP, et al. Human colostral phagocytes eliminate enterotoxigenic Eschechia coli opsonized by colostrum supernatant. J Microbiol Immunol Infec. 2011;44:1-7.
4. Newburg DS. Innate immunity and human milk. J Nutr. 2005;135:1308-12.
5. Morceli G, Honorio-França AC, Fagundes DLG, Calderon IMP, França EL. Antioxidant effect of melatonin on the functional activity of colostral phagocytes in diabetic women. PLoS One. 2013;8:e56915.
6. Fagundes DLG, França EL, Hara CCP, Honorio-França AC. Immunomodulatory effects of poly (ethylene glycol) microspheres adsorbed with cortisol on activity of colostrum phagocytes. Int J Pharmacol. 2012;8:510-8.
7. Islam SK, Ahmed L, Khan MN, Huque S, Begum A, Yunus AB. Immune components (IgA, IgM, IgG immune cells) of colostrum of Bangladeshi mothers. Pediatr Int. 2006;48:543-8.
8. Honorio-França AC, Hara CCP, Ormonde JVJ, Triches GN, França EL. Human colostrum melatonin exhibits a day-night variation and modulates the activity of colostral phagocytes. J Appl Biomed. 2013;11:153-62.
9. Richani K, Soto E, Romero R, Espinoza J, Chaiworapongsa T, Nien JK, et al. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med. 2005;17:239-45.
10. Fagundes DLG, França EL, Morceli G, Rudge MVC, Calderon IMP, Honório-França AC. The role of cytokines in the functional activity of phagocytes in blood and colostrum of diabetic mothers. Clin Develop Immunol. 2013;2013:1-8.
11. Massmann PF, França EL, Souza EG, Souza MS, Brune MFSS, Honorio-França AC. Maternal hypertension induces alterations in immunological factors of colostrum and human milk. Front Life Sci. 2013;7:155-63.
12. Kverka M, Burianova J, Lodinova-Zadnikova R, Kocourkova I, Cinova J, Tuckova L, et al. Cytokine profiling in human colostrum and milk by protein array. Clin Chem. 2007;53:955-62.
13. World Health Organization. Obesity and Overweight. Fact Sheet#311. 2013. (updated March 2013). [ http://www.who.int/mediacentre/factsheets/fs311/en/ ].
14. Womack J, Tien PC, Feldman J, Shin JH, Fennie K, Anastos K, et al. Obesity and immune cell counts in women. Metabolism. 2007;56:998-1004.
15. Schmatz M, Madan J, Marino T, Davis J. Maternal obesity: the interplay between inflammation, mother and fetus. J Perinatol. 2010;30:441-6.
16. Kopelman P. Health risks associated with overweight and obesity. Obes Rev. 2007;8:13-7.
17. Andreasen KR, Andersen ML, Schantz AL. Obesity and pregnancy. Acta Obstet Gynecol Scand. 2004;83:1022-9.
18. Karlsson EA, Beck MA. The burden of obesity on infectious disease. Exp Biol Med (Maywood). 2010;235:1412-24.
19. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis. 2006;6:438-46.
20. Guelinckx I, Devlieger R, Beckers K, Vansant A. Maternal obesity: pregnancy complication, gestational weight gain and nutrition. Obes Rev. 2008;9:140-50.
21. Poston L, Harthoorn LF, Van der Beek EM. Obesity in pregnancy: implications for the mother and lifelong health of the child. A consensus statement. Pediatr Res. 2011;69:175-8.
22. Thornton CA, Jones RH, Doekhie A, Bryant AH, Beynon AL, Davies JS. Inflammation, obesity, and neuromodulation in pregnancy and fetal development. Adv Neuroimmune Biol. 2011;1:193-203.
23. Challier JC, Basu S, Bintein T, Minium J, Hotmire K, Catalano PM, et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta. 2008;29:274-81.
24. World Health Organization. Physical status: the use and interpretation of athropometry, World Health Organization Technical Report Series 854. Geneva, Switzerland: World Health Organization; 1995.
25. Morceli G, França EL, Magalhães VB, Damasceno DC, Calderon IMP, Honorio França AC. Diabetes induced immunological and biochemical changes in human colostrum. Acta Paediatr. 2011;100:550-6.
26. Young DS. Effects of drugs on clinical laboratory tests 2. 5th ed. Washington DC: AACC Press; 2000.
27. Hassiotou F, Hepworth AR, Williams TM, Twigger AJ, Perrella S, Lai CT, et al. Breastmilk cell and fat contents respond similarly to removal of breastmilk by the infant. PLoS One. 2013;8:e78232.
28. Ali MA, Strandvik B, Palme-Kilander C, Yngve A. Lower polyamine levels in breast milk of obese mothers compared to mothers with normal body weight. J Hum Nutr Diet. 2013;26:164-70.
29. Bachour P, Yafawi R, Jaber F, Choueiri E, Abdel-Razzak Z. Effects of smoking, mother's age, body mass index, and parity number on lipid, protein, and secretory immunoglobulin A concentrations of human milk. Breastfeed Med. 2012;7:179-88.
30. França EL, Silva VA, Volpato RM, Silva PA, Brune MF, Honorio-França AC. Maternal anemia induces changes in immunological and nutritional components of breast milk. J Matern Fetal Neonatal Med. 2013;26:1223-7.
31. França EL, Calderon IMP, Vieira EL, Morceli G, Honorio-França AC. Transfer of maternal immunity to newborns of diabetic mothers. Clin Develop Immunol. 2012;2012:928187.
32. França EL, Morceli G, Fagundes DLG, Rudge MVC, Calderon IMP, Honorio França AC. Secretory IgA Fcaα receptor interaction modulating phagocytosis and microbicidal activity by phagocytes in human colostrum of diabetics. APMIS. 2011;119:710-9.
33. Ahuja S, Boylan M, Hart LS, Román-Shriver C, Spallholz JE, Pence BC, et al. Glucose and insulin levels are increased in obese and overweight mothers' breast-milk. J Nutr Food Sci. 2011;2:201-6.
34. Plagemann A, Harder T, Franke K, Kohlhoff R. Long-term impact of neonatal breast-feeding on body weight and glucose tolerance in children of diabetic mothers. Diabetes Care. 2002;25:16-22.
35. Meyer BJ, Stewart FM, Brown EA, Cooney J, Nilsson S, Olivecrona G, et al. Maternal obesity is associated with the formation of small dense LDL and hypoadiponectinemia in the third trimester. J Clin Endocrinol Metab. 2013;98:643-52.
36. Sanchez-Vera I, Bonet B, Viana M, Quintanar A, Martin MD, Blanco P, et al. Changes in plasma lipids and increased low-density lipoprotein susceptibility to oxidation in pregnancies complicated by gestational diabetes: consequences of obesity. Metab Clin Exp. 2007;56:1527-33.
37. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab. 2002;87:4231-7.
38. Knopp RH, Magee MS, Walden CE, Bonet B, Benedetti TJ. Prediction of infant birth weight by GDM screening tests. Importance of plasma triglyceride. Diabetes Care. 1992;15:1605-13.
39. Ray J, Diamond P, Singh G, Bell C. Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG. 2006;113:379-86.
40. Marín MC, Sanjurjo A, Rodrigo MA, de Alaniz MJ. Long-chain polyunsaturated fatty acids in breast milk in La Plata, Argentina: relationship with maternal nutritional status. Prostaglandins Leukot Essent Fatty Acids. 2005;73:355-60.
41. Gonzalez-Quintela A, Alende R, Gude F, Campos J, Rey J, Meijide LM, et al. Serum levels of mmunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol. 2008;151:42-50.
42. Fujihashi K, McGhee JR, Lue C, Beagley KW, Taga T, Hirano T, et al. Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesis. J Clin Invest. 1991;88:248-52.
43. Honorio-França AC, Launay P, Carneiro-Sampaio MMS, Monteiro RC. Colostral neutrophils express IgA Fc receptors (CD89) lacking y chain association that mediate non-inflammatory properties of secretory IgA. J Leuk Biol. 2001;69:289-96.
44. Honorio-França AC, Carvalho MP, Isaac L, Trabulsi LR, Carneiro-Sampaio MM. Colostral mononuclear phagocytes are able to kill enteropathogenic Escherichia coli opsonized with colostral IgA. Scand J Immunol. 1997;46:59-66.
45. Hernández-Mijares A, Jarabo-Bueno MM, López-Ruiz A, Solá-Izquierdo E, Morillas-Ariño C, Martínez-Triguero ML. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors. Int J Obes (Lond). 2007;31:927-32.
46. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal. 2004;18:1-8.
47. Gabrielsson BG, Johansson JM, Lönn M, Jernås M, Olbers T, Peltonen M, et al. High expression of complement components in omental adipose tissue in obese men. Obes Res. 2003;11:699-708.
48. Andrews E, Feldhoff P, Feldhoff R, Lassiter H. Comparative effects of cytokines and cytokine combinations on complement component C3 secretion by HepG2 cells. Cytokine. 2003;23:164-9.
49. Das UN. Is obesity an inflammatory condition? Nutrition. 2001;17:953-66.
50. Stewart FM, Freeman DJ, Ramsay JE, Greer IA, Caslake M, Ferrell WR. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab. 2007;92:969-75.
51. Bugatto F, Fernández-Deudero A, Bailén A, Fernández-Macías R, Hervías-Vivancos B, Bartha JL. Second-trimester amniotic fluid proinflammatory cytokine levels in normal and overweight women. Obstet Gynecol. 2010;115:127-33.